Table 1 Patient demographics
Group A | Group B | Group C | p value | |
|---|---|---|---|---|
Chronic type | HD-responsive type | Fatigue-free type | ||
N | 16 (15.2%) | 30 (28.6%) | 59 (56.2%) | (100.0%) |
Age (years) | 66.2 ± 14.7 | 67.7 ± 11.4 | 66.0 ± 10.8 | 0.08 |
Male (%) | 7 (43.8%) | 18 (60.0%) | 37 (62.7%) | 0.55 |
HD vintage (months) | 145 ± 133 | 140 ± 129 | 95 ± 86 | 0.09 |
Presence of DM | 8 (50.0%) | 18 (60.0%) | 33 (55.9%) | 0.94 |
History of CVD | 6 (37.5%) | 11 (36.7%) | 17 (28.8%) | 0.85 |
Prescription of antihypertensive agent | 8 (50.0%) | 20 (66.7%) | 34 (57.6%) | 0.71 |
Dry weight (kg) | 58.2 ± 14.8 | 56.5 + 13.8 | 60.9 + 15.6 | 0.41 |
CTR (%) | 49.3 ± 4.5 | 47.7 ± 4.8 | 47.3 ± 4.8 | 0.34 |
Pre-SBP | 161 ± 18 | 158 ± 26 | 157 ± 26 | 0.81 |
Pre-DBP (mmHg) | 86 1 12 | S0 ± 11 | 81 + 14 | 0.30 |
Post-SBP | 134 ± 20 | 125 ± 16 | 134 ± 18 | 0.07 |
Post-DBP (mmHg) | 75 ± 16 | 65 ± 10 | 72 ± 12 | 0.01 |
UF volume (kg) | 2.8 ± 0.5 | 2.7 ± 0.7 | 2.8 ± 0.7 | 0.66 |
Creatinine (mg/dL) | 10.0 ± 2.9 | 9.2 ± 1.9 | 9.4 ± 2.5 | 0.52 |
Hemoglobin (g/dL) | 11.2 ± 1.8 | 10.8 ± 0.8 | 11.1 ± 0.9 | 0.21 |